Opportunities & Announcements

All NIAID-relevant grant funding opportunity announcements (FOAs) are listed here. Find amendments inside the FOAs. Subscribe for Email Updates for our opportunities. Also see NIAID Contract Solicitations or Find a Foundation or Other Funding Source outside NIH.

Showing results filtered by:
Title Activity Code Posting Date Expiration Date
NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed)- PAR-19-281 R34 May 15, 2019 May 14, 2022
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-19-274 R01 May 8, 2019 May 8, 2022
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-19-275 R21 May 8, 2019 May 8, 2022
PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed- PA-19-270 R41/R42 May 7, 2019 April 7, 2020
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed- PA-19-272 R43/R44 May 7, 2019 April 7, 2020
HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)- RFA-AI-19-041 U01 May 2, 2019 September 5, 2019
HLA and KIR Region Genomics in Immune-Mediated Diseases (U19 Clinical Trial Not Allowed)- RFA-AI-19-044 U19 May 2, 2019 September 5, 2019
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)- PAR-19-262 Si2/R00 May 1, 2019 August 31, 2019
HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required)- RFA-AI-19-045 UM1 May 1, 2019 November 19, 2019
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (U01 Clinical Trial Not Allowed)- RFA-AI-19-030 U01 April 11, 2019 July 23, 2019
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01 Clinical Trial Not Allowed)- PAR-19-248 R01 April 11, 2019 June 11, 2021
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21 Clinical Trial Not Allowed)- PAR-19-247 R21 April 11, 2019 June 19, 2021
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)- PAR-19-244 R25 April 9, 2019 June 5, 2021
Building Interdisciplinary Research Careers in Women's Health (BIRCWH); K12 Clinical Trial Optional- RFA-OD-19-020 K12 April 8, 2019 May 30, 2019
Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)- PA-19-237 R21 April 3, 2019 May 8, 2022
Targeted Prevention for Tickborne Diseases (R01 Clinical Trial Not Allowed)- RFA-AI-19-037 R01 April 2, 2019 August 7, 2019
Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01 Clinical Trial Optional)- RFA-AI-19-036 R01 March 29, 2019 July 31, 2019
Development of Sample Sparing Assays for Monitoring Immune Responses (U24 Clinical Trial Not Allowed)- RFA-AI-19-017 U24 March 27, 2019 July 31, 2019
Limited Competition: Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY) (U01 Clinical Trial Not Allowed)- RFA-DK-18-512 U01 March 25, 2019 June 4, 2019
Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2 Clinical Trial Not Allowed)- PAR-19-229 UH2 March 22, 2019 October 2, 2019
Atopic Dermatitis Research Network Leadership Center (UM1) Clinical Trial Required- RFA-AI-19-014 UM1 March 18, 2019 July 9, 2019
Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional)- RFA-AI-19-015 U01 March 18, 2019 July 9, 2019
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional)- RFA-AI-19-025 U01 March 15, 2019 July 27, 2019
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (R01 Clinical Trial Optional)- RFA-AI-19-022 R01 March 15, 2019 July 27, 2019
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (U01 Clinical Trial Optional)- RFA-AI-19-023 U01 March 15, 2019 July 27, 2019
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional)- RFA-AI-19-024 R01 March 15, 2019 July 27, 2019
Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed)- RFA-AI-19-028 U01 March 5, 2019 June 29, 2019
Emerging Infectious Diseases Research Centers - Coordination Center (U01 Clinical Trial Not Allowed)- RFA-AI-19-029 U01 March 4, 2019 June 29, 2019
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)- PAR-19-209 R01 March 4, 2019 May 7, 2021
Limited Competition: Nonhuman Primate (NHP) Radiation Survivor Cohort (RSC) (U01 Clinical Trial Not Allowed)- RFA-AI-19-010 U01 February 25, 2019 June 1, 2019
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)- PA-19-188 F32 February 22, 2019 January 8, 2022
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)- PA-19-191 F30 February 22, 2019 January 8, 2022
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)- PA-19-192 F30 February 22, 2019 January 8, 2022
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)- PA-19-195 F31 February 22, 2019 January 8, 2022
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)- PA-19-196 F31 February 22, 2019 January 8, 2022
Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed)- RFA-AI-19-012 U19 February 8, 2019 June 1, 2019
Computational Models of Immunity (U01 Clinical Trial Not Allowed)- RFA-AI-19-011 U01 January 30, 2019 June 11, 2019
HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required)- RFA-AI-19-001 UM1 January 24, 2019 August 2, 2019
HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1 Clinical Trial Required)- RFA-AI-19-002 UM1 January 24, 2019 August 2, 2019
HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-003 UM1 January 24, 2019 August 2, 2019
HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-004 UM1 January 24, 2019 August 2, 2019
HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-005 UM1 January 24, 2019 August 2, 2019
HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-006 UM1 January 24, 2019 August 2, 2019
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)- PAR-19-158 R01 January 8, 2019 January 8, 2022
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)- PAR-19-134 R15 December 21, 2018 January 8, 2022
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed)- PA-19-122 K24 December 20, 2018 January 8, 2022
Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Not Allowed)- PA-19-124 K25 December 20, 2018 January 8, 2022
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)- PA-19-126 K01 December 20, 2018 January 8, 2022
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)- PA-19-130 K99/R00 December 20, 2018 January 8, 2022
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)- PA-19-117 K08 December 20, 2018 January 8, 2022
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)- PA-19-119 K23 December 20, 2018 January 8, 2022
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)- PA-19-121 K24 December 20, 2018 January 8, 2022
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)- PA-19-096 R01 November 29, 2018 January 8, 2022
Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)- PAS-19-097 R01 November 29, 2018 January 8, 2022
Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed)- PA-19-080 R01 November 26, 2018 January 8, 2022
Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed)- PA-19-081 R21 November 26, 2018 January 8, 2022
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)- PA-19-082 R01 November 26, 2018 January 8, 2022
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)- PA-19-083 R21 November 26, 2018 January 8, 2022
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)- PAR-19-078 R01 November 26, 2018 January 8, 2022
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)- PAR-19-079 R21 November 26, 2018 January 8, 2022
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)- PA-19-077 R01 November 26, 2018 January 8, 2022
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)- PA-19-066 R21 November 13, 2018 January 8, 2022
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)- PA-19-067 R01 November 13, 2018 January 8, 2022
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)- PA-19-068 R21 November 13, 2018 January 8, 2022
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)- PA-19-052 R03 November 5, 2018 January 8, 2022
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)- PA-19-053 R21 November 5, 2018 January 8, 2022
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)- PA-19-054 R21 November 5, 2018 January 8, 2022
Research Project Grant (Parent R01 Clinical Trial Required)- PA-19-055 R01 November 5, 2018 January 8, 2022
Research Project Grant (Parent R01 Clinical Trial Not Allowed)- PA-19-056 R01 November 5, 2018 January 8, 2022
Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)- PA-19-050 R21 November 1, 2018 September 8, 2021
Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)- PA-19-042 R01 November 1, 2018 September 8, 2021
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)- PA-19-029 October 17, 2018 February 3, 2021
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)- PA-19-020 R21 October 5, 2018 January 8, 2022
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)- PA-18-935 Supp October 3, 2018 January 25, 2022
Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp)- PA-18-926 Supp September 18, 2018 April 2, 2021
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)- PAR-18-923 R21 September 17, 2018 January 15, 2021
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)- PA-18-906 Supp August 22, 2018 September 8, 2021
CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed) - PAR-18-895 R01 August 8, 2018 January 8, 2021
Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional)- PAR-18-879 U01 July 26, 2018 December 4, 2020
Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed)- PA-18-872 R21 July 24, 2018 September 8, 2021
Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed)- PA-18-873 R01 July 24, 2018 September 8, 2021
Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)- PAR-18-860 R21 July 19, 2018 October 16, 2020
Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed)- PA-18-858 R21 July 18, 2018 September 8, 2021
Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)- PA-18-859 R01 July 18, 2018 September 8, 2021
Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required)- RFA-AI-18-022 U01 June 28, 2018 October 10, 2019
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)- PAR-18-840 D43 June 26, 2018 July 26, 2019
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)- PA-18-837 Supp June 20, 2018 September 5, 2021
Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)- PAR-18-822 R01 June 7, 2018 September 5, 2020
Administrative Supplements for Research on Dietary Supplements (Admin Supp - Clinical Trial Not Allowed)- PA-18-817 Supp June 5, 2018 April 16, 2020
Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed)- PAR-18-781 R21 May 11, 2018 September 10, 2020
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)- PAR-18-764 R01 April 20, 2018 May 8, 2021
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trial Not Allowed)- PA-18-754 R21 April 11, 2018 May 8, 2021
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional)- PA-18-753 R01 April 11, 2018 May 8, 2021
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)- PA-18-728 R21 March 28, 2018 January 8, 2021
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)- PA-18-729 R01 March 28, 2018 January 8, 2021
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)- PA-18-722 R01 March 28, 2018 May 8, 2021
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)- PA-18-723 R21 March 28, 2018 May 8, 2021
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) - PA-18-724 R21 March 28, 2018 May 8, 2021
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed)- PA-18-725 R01 March 28, 2018 May 8, 2021
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)- PAR-18-712 R01 March 15, 2018 May 8, 2021
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)- PAR-18-714 R15 March 14, 2018 May 8, 2021
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)- PAR-18-679 K99/R00 February 23, 2018 May 8, 2020
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed)- PA-18-652 R21 February 12, 2018 January 8, 2021
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional)- PA-18-651 R01 February 12, 2018 January 8, 2021
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)- PA-18-648 R13 February 9, 2018 January 8, 2021
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)- PAR-18-632 U44 February 6, 2018 January 14, 2021
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)- PAR-18-633 U01 February 6, 2018 January 14, 2021
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)- PAR-18-630 R01 February 5, 2018 December 7, 2019
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)- PA-18-589 January 26, 2018 January 26, 2021
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)- PA-18-590 January 26, 2018 January 26, 2021
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)- PA-18-591 Supp January 25, 2018 January 26, 2021
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )- PA-18-592 Supp January 25, 2018 September 8, 2021
Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)- PA-18-525 R43/R44 December 19, 2017 January 6, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)- PA-18-403 T32 November 21, 2017 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)- PA-18-404 T35 November 21, 2017 January 8, 2021
Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)- PAR-18-411 R01 November 16, 2017 March 14, 2020
Trophoblast Differentiation and Function (R21 Clinical Trial Optional)- PA-18-047 R21 November 15, 2017 January 8, 2020
Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)- PA-18-048 R21 November 15, 2017 January 8, 2020
Global Infectious Disease Research Administration Development Award for Low- and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)- PAR-18-335 G11 October 31, 2017 August 1, 2020
Understanding the Early Development of the Immune System (R01 - Clinical Trial Not Allowed)- PAR-18-333 R01 October 25, 2017 December 6, 2019
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)- PAR-18-319 P01 October 13, 2017 March 14, 2020
Research on Transgender Health (R21) - PA-17-477 R21 September 8, 2017 January 8, 2021
Research on Transgender Health (R01)- PA-17-478 R01 September 8, 2017 January 8, 2021
Detection of HIV for Self-Testing (R61/R33)- PAR-17-471 R61/R33 August 25, 2017 December 7, 2019
Stimulating Access to Research in Residency (StARR) (R38)- RFA-HL-18-023 R38 August 23, 2017 May 13, 2020
NIAID Research Education Program (R25)- PAR-17-455 R25 August 11, 2017 December 6, 2019
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)- PA-17-446 R21 August 1, 2017 September 8, 2020
Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)- PA-17-445 R03 August 1, 2017 September 8, 2020
Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03) - PAR-17-439 R03 July 28, 2017 September 8, 2020
Assay development and screening for discovery of chemical probes or therapeutic agents (R01)- PAR-17-438 R01 July 27, 2017 September 8, 2020
Small Grants on Primary Immunodeficiency Diseases (R03)- PAR-17-332 R03 July 21, 2017 July 17, 2019
Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)- PAR-17-333 R21 July 21, 2017 July 17, 2019
NIAID Physician-Scientist Pathway to Independence Award (K99/R00)- PAR-17-329 K99/R00 July 20, 2017 May 8, 2020
Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)- PA-17-306 R21 June 7, 2017 May 8, 2020
Imaging the Persistent HIV Reservoir (R01)- PA-17-305 R01 June 6, 2017 May 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)- PA-17-282 R21 May 12, 2017 September 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)- PA-17-283 R01 May 12, 2017 September 8, 2020
Innovation for HIV Vaccine Discovery (R01)- PAR-17-263 R01 April 25, 2017 August 2, 2019
Centers for AIDS Research (P30)- PAR-17-237 P30 March 30, 2017 August 18, 2019
Developmental Centers for AIDS Research (P30)- PAR-17-238 P30 March 30, 2017 August 18, 2019
International Research in Infectious Diseases, including AIDS (R01) - PAR-17-142 R01 January 27, 2017 August 23, 2019
Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)- PA-17-113 R01 January 9, 2017 January 8, 2020
NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)- PA-17-114 R01 January 9, 2017 January 8, 2020
HIV-1 Infection of the Central Nervous System (R01)- PA-17-100 R01 January 5, 2017 January 8, 2020
Eradication of HIV-1 From Central Nervous System Reservoirs (R01)- PA-17-084 R01 December 13, 2016 January 8, 2020
Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)- PAR-17-035 R43/R44 October 27, 2016 September 6, 2019
Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)- PAR-17-036 R41/R42 October 27, 2016 September 6, 2019
Trophoblast Differentiation and Function (R01)- PA-16-445 R01 September 23, 2016 January 8, 2020
Support of Competitive Research (SCORE) Pilot Project Award- PAR-16-438 SC2 September 21, 2016 September 8, 2019
Support of Competitive Research (SCORE) Research Advancement Award - PAR-16-439 SC1 September 21, 2016 September 8, 2019
NIAID Career Transition Award- PAR-16-434 K22 September 16, 2016 September 8, 2019
NIAID Resource-Related Research Projects- PAR-16-412 R24 August 18, 2016 September 8, 2019
NIAID Investigator-Initiated Program Project Applications- PAR-16-413 P01 August 18, 2016 January 8, 2020
Serious Adverse Drug Reaction Research (R01)- PAR-16-275 R01 May 19, 2016 September 8, 2019
Serious Adverse Drug Reaction Research (R21)- PAR-16-274 R21 May 19, 2016 September 8, 2019
Novel Approaches to Understanding, Preventing, and Treating Lyme Disease and Tickborne Coinfections (R01)- PA-16-243 R01 May 9, 2016 September 8, 2019
Novel Approaches to Understanding, Preventing, and Treating Lyme Disease and Tickborne Coinfections (R21)- PA-16-244 R21 May 9, 2016 September 8, 2019